Maquet Medical Systems USA has now officially launched two new intensive care ventilators, SERVO-U®, and its dedicated neonatal intensive care solution, SERVO-n®.
Background
Cleared by the U.S. FDA in December 2015, Maquet says the launch of SERVO-U and SERVO-n marks the latest advancement in its longstanding leadership in mechanical ventilation and innovation with the SERVO® brand.
SERVO-U represents the next step to making protective ventilation more accessible, understandable and easy to implement, putting solutions at clinicians’ fingertips to support the delivery of tailored patient care. At its foundation is a completely touch-based interface that empowers users to manage ventilation in a highly intuitive and timesaving manner. The platform, which can be used on neonates through adults, supports efficient workflow in the fast-paced intensive care environment through on-screen, context-based guidance and clinical support tools that help facilitate the implementation of the various ventilation protocols.
SERVO-n was created to help clinicians provide vulnerable neonatal and infant patients with the support they need while protecting the lungs, brain, and other developing organs. It is both sensitive and responsive in conventional modes of ventilation and compensates for variable leakage. New hot-wire anemometer flow sensor technology works in conjunction with the internal sensor of the SERVO-n to trigger, measure, and deliver the desired pressure levels and tidal volumes down to 2ml. It also includes both Neurally Adjusted Ventilatory Assist (NAVA®) and non-invasive NAVA modes as standard to help clinicians match respiratory support to the often irregular breathing patterns of neonates, resulting in less work of breathing, lower peak pressures and FiO2 requirements, and improved comfort.
Company comments
“SERVO-U and SERVO-n are quintessential Maquet products as each boasts our rich heritage in, and company-wide commitment to innovation in ventilation,” said Raoul Quintero, President, Americas, Getinge Group. “Both ventilation platforms will allow us to bring additional, user-friendly support tools to clinicians at a time when care practice optimization is more important than ever. A clinician’s ability to tailor ventilation to individual patient needs, through the intuitive user interface and the system’s advanced capabilities like NAVA, is essential within the critical care environment. We believe that once our customers have tried SERVO-U and SERVO-n, they will never look at mechanical ventilators in the same way again.”
Source: PR Newswire
published: January 6, 2016 in: Approval/Clearance, Launches / Withdrawals, Monitoring, Thoracic/Respiratory